HIGH

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.

cGMP deviations.

Quick Facts at a Glance

Recall Date
April 1, 2026
Hazard Level
HIGH
Brand
Wells Pharma of Houston
Geographic Scope
1 states

Hazard Information

cGMP deviations.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Wells Pharma of Houston LLC or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Wells Pharma of Houston recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.. Reason: cGMP deviations.. Classification: Class II. Quantity: 50 syringes. Distribution: U.S. Nationwide.

View Original Recall on FDA - Drug Safety

Browse More Recalls

More from FDA_DRUGHealth & Personal CareDrugs & Medications

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Lot 011226204250063
Exp Date 05/14/2026
Affected States
ALL
Report Date
May 6, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls